Certain information that is included in this investor presentation may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or the Securities and Exchange Commission that may involve a number of risks and uncertainties. These statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties and assumptions. Actual future results may vary significantly based on a number of factors that may cause the actual results or events to be materially different from future results, performance or achievements expressed or implied by these statements. We have identified various risk factors associated with our operations in our most recent annual report and other filings with the Securities and Exchange Commission.

Cautionary Statement Regarding Forward-Looking Information

Company Overview

• Formed in 1996

• Leading marketer of pet medications and other health products for dogs and cats direct to the consumer.

• Markets its products through national advertising campaigns, which direct the consumer to order by phone or on the internet, and aim to increase recognition of the "1-800-PetMeds" brand name.

• Provides an attractive alternative for obtaining pet medications in terms of convenience, price, ease of ordering and rapid home delivery.

$0.0

$50.0

$100.0

$150.0

$200.0

$250.0

$300.0

FY 2018 FY 2019

$273.8 $283.4

The Leading Direct Marketer of Pet Medications Annual Sales (in millions)

Chart1

FY 2018

FY 2019

273.8

283.4

Sheet1

FY 2018FY 2019

$273.8$283.4

$230.3 $240.0

$0.0

$50.0

$100.0

$150.0

$200.0

$250.0

FY 2018 FY 2019

E-Commerce Annual Sales (in millions)

Fast, Easy, Helpful Service With Great Savings

• Consumers generally save money from veterinarians' prices.

• Consumers enjoy the convenience of rapid home or office delivery.

• Exceptional customer care and support is our top priority.

Exceptional Customer Service

0%

25%

50%

75%

100%

Jun-1

8

Sep-1

8

Dec-1

8

Mar-1

9 PETSAVG

Net Promoter Score

PETS 82.5%

AVG 45.0%

(1)

(1)NPS Benchmark Study, December 2018, www.netpromoter.com average for online shopping.

• Net Promoter Score = 82.5% in the top 2 % of companies

• Google Seller Rating = 4.7/5.0

• Average email response time is less than 10 minutes vs 24 hours

http://www.netpromoter.com/

Pet Medications

• Flea & Tick Preventatives• Heartworm Preventives• Arthritis, Thyroid, Heart, Blood Pressure• Skin, Dental, Ear, Eye Care• Vitamins & Nutritional Supplements

$72.6 Billion Pet Market in U.S.4.4% Growth in 2018

According to American Pet Products Manufacturers Association (APPMA).

$16.0

$18.1

$6.1$2.0

$30.4

Food 4.3% Growth

Vet Care -6.2% Growth

Supplies/Medicine 19.9% GrowthGrooming/Boarding -0.8% GrowthAnimalPurchases -4.3% Growth

Pet Medications Market Share $5 Billion (Estimated)

According to IMS Health and NACDS Economics Dept., in human pharmaceuticals, 19% of the market is serviced by mail order/on-line channel.

58% 6%

6%

30%

Veterinarians

Retailers

1-800-PetMeds

Other Mail OrderPure Plays

Sales Seasonality TrendsFiscal Year Ended March 31, 2018

31%

23%

21%

25%

1st Q EndingJune 30, $87.4 million

2nd Q EndingSeptember 30,$71.4 million

3rd Q EndingDecember 31,$60.1 million

4th Q EndingMarch 31, $64.5 million

$80.0

$85.0

$90.0

$95.0

$100.0

FY 2018 FY 2019

$87.0 $87.0

Average Order Value

For the three months ended March 31, 2019, AOV was $85 compared to $89 for the same period the prior year.

Chart1

FY 2018

FY 2019

87

87

Sheet1

FY 2018FY 2019

$87.0$87.0

$0.0

$10.0

$20.0

$30.0

$40.0

$50.0

FY 2018 FY 2019

$37.0

$47.0

Customer Acquisition Cost

For the three months ended March 31, 2019, CAC was $65 compared to $38 for the same period the prior year.

Chart1

FY 2018

FY 2019

37

47

Sheet1

FY 2018FY 2019

$37.0$47.0

Competitive Strengths• Channel leader

• “1-800-PetMeds” brand name

• Licensed pharmacy to do business in 50 states –Pharmacy verified website

• Superior service – Fast, Easy and Helpful – Most consumers do not have hard copy prescriptions. We do the work for them.

• 1,000 SKUs in stock, and 2,000 SKUs via third party

$20.0

$30.0

$40.0

FY 2018 FY 2019

$37.3 $37.7

Annual Net Income(in millions)

Chart1

FY 2018

FY 2019

37.3

37.7

Sheet1

FY 2018FY 2019

$37.3$37.7

$1.50

$2.00

FY 2018 FY 2019

$1.82 $1.84

Diluted EPS(per share)

Chart1

FY 2018

FY 2019

1.82

1.84

Sheet1

FY 2018FY 2019

1.821.84

0.0%

10.0%

20.0%

30.0%

40.0%

FY 2018 FY 2019

35.7%33.6%

Gross Profit Margin

For the three months ended March 31, 2019 and 2018, gross profit margin was 32.1% and 37.0%, respectively.

Chart1

FY 2018

FY 2019

0.357

0.336

Sheet1

FY 2018FY 2019

35.7%33.6%

Summary Financial Data (in millions)

New Order Revenue 41.6$ 14.7% 46.3$ 16.9%Reorder Revenue 241.8$ 85.3% 227.5$ 83.1%Total Net Revenue 283.4$ 273.8$ Gross Profit 95.3$ 33.6% 97.8$ 35.7%G&A Expenses 24.8$ 8.7% 24.3$ 8.9%Advertising Expenses 22.1$ 7.8% 19.3$ 7.0%Depreciation Expenses 2.2$ 0.8% 2.1$ 0.8%Operating Income 46.2$ 16.3% 52.1$ 19.0%Net Income 37.7$ 13.3% 37.3$ 13.6%EPS - Diluted 1.84$ 1.82$ Dividends Declared 1.06$ 0.85$

FY 2019 FY 2018

Sheet1

FY 2019FY 2018

New Order Revenue$ 41.614.7%$ 46.316.9%

Reorder Revenue$ 241.885.3%$ 227.583.1%

Total Net Revenue$ 283.4$ 273.8

Gross Profit$ 95.333.6%$ 97.835.7%

G&A Expenses$ 24.88.7%$ 24.38.9%

Advertising Expenses$ 22.17.8%$ 19.37.0%

Depreciation Expenses$ 2.20.8%$ 2.10.8%

Operating Income$ 46.216.3%$ 52.119.0%

Net Income$ 37.713.3%$ 37.313.6%

EPS - Diluted$ 1.84$ 1.82

Dividends Declared$ 1.06$ 0.85

4 Compelling ReasonsTo invest in 1-800-PetMeds

1. Leader in its channel in an estimated $5 billion industry

2. 1-800-PetMeds brand name

3. Licensed pharmacy to conduct business in 50 states

4. Exceptional customer service and support

Slide Number 1Slide Number 2Slide Number 3Slide Number 4Slide Number 5Slide Number 6Exceptional Customer ServiceSlide Number 8Slide Number 9Slide Number 10Slide Number 11Slide Number 12Slide Number 13Slide Number 14Slide Number 15Slide Number 16Slide Number 17Slide Number 18Summary Financial Data (in millions)Slide Number 20